APA (7th ed.) Citation

YH, L., SY, L., T, Y., YS, X., HL, W., CL, F., & W, T. (2026). PDE4 inhibitor apremilast ameliorates TNBS-induced irritable bowel syndrome in mice by activating the Nrf-2 signaling pathway in enteric glial cells. Acta pharmacologica Sinica, 47(1), 135. https://doi.org/10.1038/s41401-025-01649-w

Chicago Style (17th ed.) Citation

YH, Lu, Lei SY, Yang T, Xu YS, Wang HL, Feng CL, and Tang W. "PDE4 Inhibitor Apremilast Ameliorates TNBS-induced Irritable Bowel Syndrome in Mice by Activating the Nrf-2 Signaling Pathway in Enteric Glial Cells." Acta Pharmacologica Sinica 47, no. 1 (2026): 135. https://doi.org/10.1038/s41401-025-01649-w.

MLA (9th ed.) Citation

YH, Lu, et al. "PDE4 Inhibitor Apremilast Ameliorates TNBS-induced Irritable Bowel Syndrome in Mice by Activating the Nrf-2 Signaling Pathway in Enteric Glial Cells." Acta Pharmacologica Sinica, vol. 47, no. 1, 2026, p. 135, https://doi.org/10.1038/s41401-025-01649-w.